VRTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 490.39 USD 2.38% Market Closed

Market Cap: $124.5B

	Vertex Pharmaceuticals Inc NASDAQ:VRTX	US
	Barratt Developments P L C F:3BAA	UK
F	Fleetcor Technologies Inc XBER:07G	US
	Prysmian SpA F:AEU	IT
E	Endo International PLC F:EO7	IE
	Currys PLC LSE:CURY	UK
	Koninklijke Ahold Delhaize NV AEX:AD	NL
N	Norfolk Southern Corp XHAM:NFS	US
C	Caixabank SA XMUN:48CA	ES
	NN Group NV AEX:NN	NL
	Walmart Inc NASDAQ:WMT	US
B	Bluebik Group PCL SET:BBIK	TH
	Sekisui Chemical Co Ltd F:SUI	JP
	Sanofi SA PAR:SAN	FR
T	Takkt AG F:TTK	DE

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

41%

Declining Operating Margin

47% > 39%

Exceptional Net Margin

36%

Sustainable 3Y Average Net Margin

21%

Net Margin is Increasing

35% > 36%

Exceptional Free Cash Flow Margin

26%

Strong 3Y Average Free Cash Flow Margin

18%

Declining Free Cash Flow Margin

41% > 26%

Positive ROE

24%

Positive 3Y Average ROE

Positive 3Y Average ROIC

11%

Declining ROIC

47% > 25%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.